Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Intralesional Laser Therapy for Dermal Filler Complications

Published: Mon, 18 Jun 2018 12:00:00 EDT
Is intralesional laser treatment a safe and effective treatment option for complications caused by dermal filler treatments?
Plastic and Reconstructive Surgery

Health Insurance Coverage by Occupation Among Adults

Published: Mon, 18 Jun 2018 12:00:00 EDT
Are workers in certain occupations more likely to be uninsured? Did this change significantly after the ACA went into effect in 2014?
Morbidity & Mortality Weekly Report

Troponin-I Levels and Outcome in Patients With High CVD Risk

Published: Mon, 18 Jun 2018 12:00:00 EDT
Might troponin-I elevation serve as a prognostic marker for hospital mortality in critically ill patients with a high prevalence of cardiovascular risk factors?
BMC Anesthesiology

Pheochromocytoma/Paraganglioma and Cancer Metabolism

Published: Mon, 18 Jun 2018 12:00:00 EDT
A better understanding of the metabolic pathophysiology in pheochromocytomas/paragangliomas may lead to more targeted treatment for these tumors.
Journal of Clinical Endocrinology & Metabolism
Displaying results 9-12 (of 20)
 1 - 2 - 3 - 4 - 5 

HEALTHCARE SUPPLIER NEWS

Calliditas files for $75M IPO to fund kidney disease phase 3

Published: Thu, 14 Jun 2018 13:10:32 +0000
Calliditas has filed to raise SEK 650 million ($75 million) through an IPO in Sweden. The financing will set Calliditas up to start enrolling autoimmune kidney disease patients in a pivotal trial later this year.

Apexigen, BMS to combine CD40 and anti-CSF-1 drugs with Opdivo in new study

Published: Thu, 14 Jun 2018 13:01:44 +0000
Apexigen is collaborating with Yale Cancer Center on an early-stage clinical trial that combines the biotech’s APX005M CD40 activator with Bristol-Myers Squibb’s Opdivo and cabiralizumab, an investigational anti-CSF-1 antibody, in patients with advanced solid tumors.

U.K. creates £2.5B investment program to help startups grow

Published: Thu, 14 Jun 2018 12:05:49 +0000
The U.K. has set up a £2.5 billion ($3.6 billion) patient capital program. The fund is part of an initiative to help British biotechs grow into standalone midsized businesses, rather than sell up at the first sign of a takeover bid from overseas.

Alta raises $130M for its new biotech VC fund, missing its $200M goal

Published: Wed, 13 Jun 2018 17:51:12 +0000
Healthcare venture capital firm Alta Partners has launched a new fund focused on companies developing new therapeutics and health technology services. It closed with $130 million, below the $200 million it had hoped to raise according to a February 2017 SEC filing.
Displaying results 9-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top